Join us for a Special Meetup: Managing the Emotions of MBC at a Young Age - Jan 29, 2025 at 1pm ET Register here.
Join our Webinar: REAL Talk: Healthy Body and Mind After Breast Cancer Treatment - Jan 23, 2025 at 4pm ET Register here.

FDA Approves Orserdu for ER+ MBC (oral SERD)

FDA Approves Orserdu for Metastatic, Estrogen Receptor-Positive Breast Cancer
Jan 27, 2023

The FDA has approved Orserdu, a new oral medicine to treat metastatic, estrogen receptor-positive, HER2-negative breast cancer with an ESR1 mutation. Read more....